NexusTrade Loading NexusTrade… Taking too long? Reload this page

About Treace Medical Concepts, Inc. Common Stock (TMCI)

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to correct three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible correction of metatarsus adductus deformities and osteoarthritis of the midfoot. It serves physicians, surgeons, ambulatory surgery centers and hospitals related to the surgical management of bunion and related midfoot deformities. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Ticker
TMCI
Exchange
XNAS
Sector
Healthcare
Industry
Medical Devices

Company profile updated October 11, 2026.

Stored market snapshot

As of October 9, 2026. Daily closing data may differ from the live quote shown in the dashboard.

Stored daily close (USD)
$3.95
Company market capitalization (USD)
$256,886,480.4
Price / book
3.79×

Research TMCI

Compare the company’s price history and fundamentals in the dashboard. Explore disclosed trading and ownership activity in these research collections: